Darren Mooney
Pfm Health Sciences, Lp
Assets Managed
$1.097B
Holdings
79
Last Quarter
2026 - Q1
Filed Date
1d ago
Growth Rate
9.35%(2Q avg: -6.76%)
Sustained Growth
1 quarters
Portfolio positions
This chart displays the top 10 holdings in Pfm Health Sciences, Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 79 positions.
Assets under management
The assets under management (AUM) of Pfm Health Sciences, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.097B in assets, with a quarterly growth rate of 9.35% and a 2-quarter average growth rate of -6.76%. The portfolio is managed by Darren Mooney, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
THC Tenet Healthcare Corp
| 6.86% | $75.214M 398,567 shares@ $188.72 avg price | Increased 0.21% |
UTHR United Therapeutics Corp
| 6.35% | $69.619M 117,405 shares@ $592.99 avg price | Increased 73.31% |
LLY Eli Lilly & Co
| 5.52% | $60.486M 65,762 shares@ $919.78 avg price | Decreased -3.7% |
XBI Spdr S&p Biotech Etf
| 5.31% | $58.155M↓ Put 455,300 shares@ $127.73 avg price | New Position |
PEN Penumbra Inc
| 4.19% | $45.899M 139,779 shares@ $328.37 avg price | Decreased -3.71% |
AXSM Axsome Therapeutics Inc
| 4.08% | $44.673M 264,304 shares@ $169.02 avg price | Increased 5.07% |
ASND Ascendis Pharma A S - Adr
| 3.64% | $39.898M 174,434 shares@ $228.74 avg price | Decreased -1.82% |
XLV Health Care Select Sector
| 3.2% | $35.025M↑ Call 238,900 shares@ $146.61 avg price | New Position |
JAZZ Jazz Pharmaceuticals Plc
| 3.08% | $33.678M 178,144 shares@ $189.05 avg price | Increased 252.69% |
NBIX Neurocrine Biosciences Inc
| 2.6% | $28.413M 215,678 shares@ $131.75 avg price | Increased 32.16% |
1-10 of 79